Comfoderm K 0,1% cream for external use 15 g
Women's clothing size
With your arms relaxed at your sides, measure around the fullest part of your chest.
Measure around the narrowest part of your natural waist, generally around the belly button. To ensure a comfortable fit, keep one finger between the measuring tape and your body.
Composition of 100 mg of cream: active substance: acepont methylprednisolone - 0.1 mg (in terms of 100% substance); auxiliary components: macrogol stearate 40 - 1.5 mg; glyceryl monostearate - 8.5 mg; potassium dihydrophosphate – 0.49 mg; ceramides - 0.5 mg; preservative Euxyl PE 9010 (ethylhexylglycerol - 10%, phenoxyethanol - 90%) - 0.9 mg (in terms of phenoxyethanol); sodium hydrogen phosphate dodecahydrate - 0.01 mg; isopropyl myristate - 7 mg; disodium edetate - 0.1 mg; octyldodecanol - 7 mg; hexyldecyl stearate - 7 mg; dimethicone 100 cst – 1 mg; cestearyl alcohol (stearyl alcohol - 40%, cetyl alcohol - 60%) - 2 mg; propylene glycol - 7 mg; purified water - up to 100 mg.
Glucocorticosteroid for topical use.
Indications for use
Inflammatory skin diseases sensitive to therapy with topical glucocorticosteroids: atopic dermatitis, neurodermatitis, childhood eczema; true eczema; microbial eczema; simple contact dermatitis; allergic (contact) dermatitis; dyshidrotic eczema.
Hypersensitivity to the components of the drug; tuberculous or syphilitic processes in the area of application of the drug; viral diseases (for example, chickenpox, shingles) in the area of application of the drug; rosacea, perioral dermatitis in the area of application of the drug; skin areas with manifestations of a reaction to vaccination; children's age up to 4 months.
Dosage and Administration
Outwardly. Adults and children from 4 months of age. The drug is applied 1 time per day in a thin layer on the affected areas of the skin. As a rule, the duration of continuous daily treatment with Comfoderm® K should not exceed 12 weeks for adults and 4 weeks for children. The drug Comfoderm® K is suitable for the treatment of suboctive and acute inflammatory processes without pronounced weaning, with the localization of the process both on smooth skin and on the scalp, including on skin prone to oiliness.
The incidence of side effects is classified according to the recommendations of the World Health Organization (WHO): very often (≥ 10%), often (≥ 1%, < 10%), infrequently (≥ 0.1%, < 1%), rarely (≥ 0.01%, < 0.1%), very rarely (< 0.01%), the frequency is unknown (it is not possible to estimate the frequency of occurrence). Disorders of the skin and subcutaneous tissues: rarely perioral dermatitis, skin depigmentation, allergic reactions to the components of the drug; the frequency of unknown skin atrophy, telangiectasia, striae, acne-like skin changes (when using the drug for more than 4 weeks and / or on an area of 10% or more of the body surface). General disorders and disorders at the injection site: rarely - folliculitis, hypertrichosis; very rarely - itching, burning, erythema, formation of vesicular rash; frequency unknown - systemic effects due to absorption of glucocorticosteroid (when using the drug for more than 4 weeks and / or on an area of 10% or more of the body surface). If any of the side effects indicated in the instructions are aggravated, or any other side effects not indicated in the instructions are noted, you should immediately inform your doctor.
At a temperature not exceeding 25 ° C. Keep out of the reach of children.
- Dosage form
- Methylprednisolone Aceponat
- INN Russian
- Метилпреднизолона ацепонат
- Russian title
- Комфодерм К